Korean J Anesthesiol.
2006 Sep;51(3):363-366. 10.4097/kjae.2006.51.3.363.
Delayed Recovery after Continuous Infusion of Midazolam in Hepatic Dysfunction: A case report
- Affiliations
-
- 1Department of Anesthesiology and Pain Medicine, Eulji Medical University, Seoul, Korea. hskang0108@eulji.or.kr
- KMID: 2237439
- DOI: http://doi.org/10.4097/kjae.2006.51.3.363
Abstract
- Benzodiazepines are frequently administered for sedation to surgical intensive care unit patients who require postoperative intubation and mechanical ventilation. Midazolam is the most commonly used drug, which is water soluble, short-acting benzodiazepine and rapidly metabolized by the liver. Continuous intravenous infusion of midazolam was administered to the man who was 40 years old for mechanical ventilation in the intensive care unit for 58 hours. After discontinued midazolam, patient who had acute hepatic dysfunction had been sedated with endotracheal intubation for 5 days. Even flumazenil was tried twice to reverse the effect of midazolam, the response was limited by the time. Finally he awaked as recovery of his hepatic function.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Delayed Recovery of Sedation by Continuous Midazolam Infusion in an ESRD Patient on Peritoneal Dialysis: A Case Report
- The Effects of Midazolam and Propofol by Continuous Intravenous Infusion to provide Sedation in Patients who receive Spinal Anesthesia
- The Effect of Co-administration of Midazolam on Induction and Recovery Using Continuous Propofol Infusion
- Sedation with Continuous Infusion of Midazolam for Ventilated Patient in Intensive Care Unit
- Continuous Infusion of Midazolam for Short-term Sedation in Critically III Patients
